Introduction: Mucosal drug delivery systems exploit mucous membranes (buccal, nasal, rectal, vaginal, ocular) to deliver drugs locally or systemically. Understanding principles and mechanisms—permeation routes, mucoadhesion, enzymatic degradation, transporters, and mucociliary clearance—helps optimize formulation, improve bioavailability, and avoid first‑pass metabolism. Key concepts include permeability barriers, physicochemical drug properties, permeation enhancers, mucoadhesive polymers, particulate carriers, and controlled‑release strategies. Practical knowledge of characterization methods, safety, and clinical examples enables rational design of effective transmucosal therapies. This set of focused MCQs is designed for B.Pharm students to reinforce mechanisms, formulation approaches, and evaluation techniques. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. Which mucosal route is most commonly used to avoid first‑pass hepatic metabolism for systemic drug delivery?
- Oral (gastrointestinal)
- Transdermal
- Nasal
- Intravenous
Correct Answer: Nasal
Q2. Which layer of the mucosa primarily determines drug permeation across most mucosal surfaces?
- Basement membrane
- Epithelium
- Lamina propria
- Serosa
Correct Answer: Epithelium
Q3. Mucoadhesion enhances drug residence time by interacting with which mucus component?
- Lipid bilayer
- Mucin glycoproteins
- Keratin
- Collagen fibers
Correct Answer: Mucin glycoproteins
Q4. Which mechanism involves transiently opening tight junctions to enhance paracellular drug transport?
- Endocytosis
- Transcytosis
- Tight junction modulation
- Efflux pump activation
Correct Answer: Tight junction modulation
Q5. Which physicochemical property of a drug most favors passive transcellular permeation across mucosal epithelium?
- High molecular weight
- High lipophilicity
- High polarity
- Strong ionization at physiological pH
Correct Answer: High lipophilicity
Q6. Which polymer is commonly used for mucoadhesive buccal formulations due to strong hydrogen bonding with mucus?
- Polyethylene glycol
- Polyvinylpyrrolidone
- Carbopol (carbomer)
- Polylactic acid
Correct Answer: Carbopol (carbomer)
Q7. Mucociliary clearance primarily affects drug retention at which mucosal site?
- Buccal mucosa
- Vaginal mucosa
- Nasal mucosa
- Corneal surface
Correct Answer: Nasal mucosa
Q8. Which transporter often reduces mucosal drug absorption by pumping substrates back into the lumen?
- GLUT1
- P-glycoprotein (P-gp)
- SGLT2
- OATP1B1
Correct Answer: P-glycoprotein (P-gp)
Q9. Which formulation approach protects peptide drugs from enzymatic degradation on mucosal surfaces?
- Use of micellar surfactants only
- Encapsulation in nanoparticles
- Increasing pH to extreme alkaline values
- Adding simple salts
Correct Answer: Encapsulation in nanoparticles
Q10. For buccal delivery, which drug property is most desirable to ensure both permeation and retention?
- Very high lipophilicity and insolubility
- Moderate lipophilicity and moderate molecular weight
- High molecular weight and high charge
- Complete hydrophilicity
Correct Answer: Moderate lipophilicity and moderate molecular weight
Q11. Which of the following is a common permeation enhancer used in nasal formulations?
- Sodium lauryl sulfate
- Saccharin
- Hydroxypropyl methylcellulose (HPMC)
- Poloxamer 188
Correct Answer: Sodium lauryl sulfate
Q12. Which route is preferred for rapid systemic onset using mucosal delivery for small volatile molecules?
- Rectal
- Nasal
- Vaginal
- Buccal
Correct Answer: Nasal
Q13. Iontophoresis across mucosa enhances drug delivery by which primary mechanism?
- Increasing temperature of mucosa
- Applying an electrical potential to drive charged molecules
- Altering mucous viscosity chemically
- Inducing enzymatic activation
Correct Answer: Applying an electrical potential to drive charged molecules
Q14. Which in vitro method is commonly used to evaluate mucosal permeation across excised tissue?
- Dissolution testing in USP I only
- Franz diffusion cell
- Gel permeation chromatography
- UV–Vis spectrophotometry alone
Correct Answer: Franz diffusion cell
Q15. Which statement about transmucosal nanoparticle carriers is TRUE?
- They always increase systemic toxicity
- They can enhance mucoadhesion and protect drugs from enzymes
- They are ineffective for hydrophobic drugs
- They eliminate the need for permeation enhancers
Correct Answer: They can enhance mucoadhesion and protect drugs from enzymes
Q16. Enzymatic degradation on mucosal surfaces primarily affects which class of drugs?
- Small nonpolar molecules
- Peptides and proteins
- Lipophilic steroids
- Inorganic salts
Correct Answer: Peptides and proteins
Q17. Which factor accelerates drug removal from oral mucosa reducing bioavailability?
- Mucin turnover and saliva flow
- Presence of keratinized epithelium only
- Low molecular weight
- High partition coefficient exclusively
Correct Answer: Mucin turnover and saliva flow
Q18. For vaginal delivery, what is a key advantage of local mucoadhesive formulations?
- Complete systemic absorption
- Prolonged local drug contact and reduced dosing frequency
- Guaranteed enzyme degradation
- Elimination of local irritation risk
Correct Answer: Prolonged local drug contact and reduced dosing frequency
Q19. Which characteristic of mucus presents a barrier to nanoparticle diffusion?
- Low water content
- Negative charge and mesh-like gel structure
- High ionic strength only
- Absence of glycoproteins
Correct Answer: Negative charge and mesh-like gel structure
Q20. Which analytical parameter assesses mucoadhesive strength of a formulation?
- Detachment force measurement
- pKa determination
- Melting point analysis
- Viscosity only at 100°C
Correct Answer: Detachment force measurement
Q21. Which mucosal route is most suitable for systemic delivery of insulin using experimental transmucosal carriers?
- Vaginal
- Buccal
- Nasal
- Rectal
Correct Answer: Nasal
Q22. Which is a major safety concern unique to mucosal drug delivery compared to oral tablets?
- Systemic first‑pass metabolism
- Local irritation and disruption of mucosal barrier
- Risk of overdosing due to taste masking
- Excessive gastrointestinal side effects
Correct Answer: Local irritation and disruption of mucosal barrier
Q23. Which excipient property aids in both mucoadhesion and controlled release?
- High crystallinity
- Hydrophilic swellable polymer behavior
- Volatile solvent content
- Strong oxidative potential
Correct Answer: Hydrophilic swellable polymer behavior
Q24. Which mechanism describes drug uptake via vesicle formation and transport across epithelial cells?
- Paracellular diffusion
- Facilitated diffusion
- Endocytosis/transcytosis
- Simple diffusion through tight junctions
Correct Answer: Endocytosis/transcytosis
Q25. Which mucosal layer contains immune cells that can influence vaccine delivery outcomes?
- Keratinized surface
- Lamina propria
- Basal lamina only
- Muscle layer
Correct Answer: Lamina propria
Q26. Which pH consideration is important for nasal formulations to minimize irritation and optimize absorption?
- Extreme alkaline pH (>10)
- pH close to nasal physiological pH (~5.5–6.5)
- Any pH is acceptable if osmolarity is high
- Extremely acidic pH (<2)
Correct Answer: pH close to nasal physiological pH (~5.5–6.5)
Q27. Which evaluation assesses the effect of mucus on nanoparticle mobility?
- Differential scanning calorimetry
- Multiple particle tracking (MPT)
- Fourier transform infrared spectroscopy
- pH titration
Correct Answer: Multiple particle tracking (MPT)
Q28. Which statement about transmucosal controlled‑release systems is CORRECT?
- They always require daily dosing
- They can maintain therapeutic levels and reduce dosing frequency
- They are unsuitable for local therapy
- They cannot use polymeric matrices
Correct Answer: They can maintain therapeutic levels and reduce dosing frequency
Q29. Which factor most reduces absorption of weakly basic drugs across acidic mucosal surfaces?
- Ionization leading to decreased membrane permeability
- Enhanced lipophilicity
- Increased transcellular diffusion
- Formation of nonionized species
Correct Answer: Ionization leading to decreased membrane permeability
Q30. Which clinical advantage is commonly achieved by successful transmucosal delivery of systemic drugs?
- Increased first‑pass hepatic metabolism
- Faster onset and potential for needle‑free administration
- Guaranteed lifetime dosing adherence
- Complete elimination of adverse effects
Correct Answer: Faster onset and potential for needle‑free administration
I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com